Twist Bioscience (TWST) PT Raised to $40 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TWST Hot Sheet
Price: $134.40 -4.21%
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Rating Summary:
12 Buy, 3 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 25 | New: 12
Join SI Premium – FREE
Baird analyst Catherine Schulte raised the price target on Twist Bioscience (NASDAQ: TWST) to $40.00 (from $39.00) while maintaining a Outperform rating.
You May Also Be Interested In
- AMD (AMD) PT Raised to $600 at DA Davidson
- People Incorporated (PPLI) PT Lowered to $58 at StoneX
- Dynatrace Inc. (DT) PT Lowered to $60 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
